At a glance
- Originator Shaanxi Weinan Aoxing Pharmaceuticals
- Developer BioStar Pharmaceuticals; Shaanxi Weinan Aoxing Pharmaceuticals
- Class Acetamides; Neuroprotectants; Nootropics; Pyrrolidinones; Small molecules
- Mechanism of Action AMPA receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cerebrovascular disorders
Most Recent Events
- 01 Jul 2019 Chemical structure information added